Urokinase in the management of occluded PICC lines;Utilisation de l'urokinase dans le traitement des occlusions de PICC-lines

Journal de Radiologie

Volumn 91, Issue 3 C1, 2010, Pages 287-291

  Muller, C ^a   Jacquier, A ^a   Varoquaux, A ^a   Cohen, F ^a   Louis, G ^a   Gaubert, J Y ^a   Moulin, G ^a   Bartoli, J M ^a   Vidal, V ^a  

^a TIMONE HOSPITAL   (France)

Author keywords

Complication; Occlusion; PICC line; Thrombolysis; Urokinase

Indexed keywords

SODIUM CHLORIDE; UROKINASE;

ARTICLE; BLOOD CLOT LYSIS; CATHETER OCCLUSION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MALE; PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER; SINGLE DRUG DOSE;

EID: 77951040603     PISSN: 02210363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0221-0363(10)70040-8     Document Type: Article

References (27)

1. Vidal V, Muller C, Jacquier A, et al. Évaluation prospective des complications des PICCs J Radiol 2008;89:495-498
2. Marcy PY, Ianessi A, Ben Taarit I. Abord brachial percutané : quelques règles simples. J Radiol 2009;90:77-78
3. Amerasekera SS, Jones CM, Patel R, et al. Imaging of the complications of peripherally inserted central venous catheters. Clin Radiol 2009;64:832-840
4. Smith SP, Friedell ML, Cheatham ML, et al. Peripherally inserted central catheters revisited. Am J Surg 1998;176:208-211
5. Walshe LJ, Malak SF, Eagan J et al. Complication rates among cancer patients with peripherally inserted central catheters. J Clin Oncol 2002;20:3276-3281
6. Farjo L. Blood collection from peripherally inserted central venous catheters: an ins- Tableau III Utilisation des thrombolytiques lors des occlusions de PICC. Thrombolytique Nombre de PICC Reperméabilisation post thrombolyse Ng 2004 Alteplase (2 mg) 240 81,1 % après 1 dose pendant 120 min 92,9 % après 2e dose pendant 120 min Bowers 2008 Alteplase 3 66 % Smith 1998 Urokinase 50 80 % Muller 2009 Urokinase 16 93,8 % titution's effort to evaluate and update its current policy. J Infus Nurs 2003;26:374-379
7. Bowers L, Speroni KG, Jones L et al. Comparison of occlusion rates by flushing solutions for peripherally inserted central catheters with positive pressure Lueractivated devices. J Infus Nurs 2008; 31:22-27
8. Randolph AG, Cook DJ, Gonzales CA et al. Benefit of heparin in peripheral venous and arterial catheters: systematic review and meta-analysis of randomised controlled trials. BMJ 1998;316:969-975
9. Goode CJ, Titler M, Rakel B, et al. A meta- analysis of effects of heparin flush and saline flush: quality and cost implications. Nurs Res 1991;40:324-330
10. Peterson FY, Kirchoff KT. Analysis of the research about heparinized versus nonheparinized intravascular lines. Heart Lung 1991;20:631-640
11. Pittiruti M, Hamilton H, Biffi R et al. ESPEN Guidelines on Parenteral Nutrition: Central Venous Catheters (access, care, diagnosis and therapy of complications). Clin Nutr 2009;28:365-377
12. Pasquale MD, Campbell JM, Magnant CM, et al. Groshong versus Hickman catheters. Surg Gynecol Obstet 1992;174:408-410
13. Jacobs BR, Schilling S, Doellman D, Hutchinson N, Rickey M, Nelson S et al. Central venous catheter occlusion: a prospective, controlled trial examining the impact of a positive-pressure valve device. JPEN J Parenter Enteral Nutr 2004;28:113-118
14. Di Giacomo M. Comparison of three peripherally- inserted central catheters: pilot study. Br J Nurs 2009;18:8-16.
15. Angle JF, Matsumoto AH, Skalak TC et al. Flow characteristics of peripherally inserted central catheters. J Vasc Interv Radiol 1997;8:569-577
16. Merrell SW, Peatross BG, Grossman MD et al. Peripherally inserted central venous catheters: low risk alternatives for ongoing venous access. West J Med 1994;160:125-130
17. Cardella JF, Cardella K, Bacci N, et al. Cumulative experience with 1273 peripherally inserted central catheters at a single institution. J Vasc Interv Radiol 1996;7:5-13.
18. Liu CY, Jain V, Shields AF et al. Efficacy and safety of reteplase for central venous catheter occlusion in patients with cancer. J Vasc Interv Radiol 2004;15:39-44.
19. Deitcher SR, Fesen MR, Kiproff PM, et al. Safety and efficacy of alteplase for restoring function in occluded central venous catheters: results of the cardiovascular thrombolytic to open occluded lines trial. J Clin Oncol 2002;20:317-324
20. Davies J, Casey J, Li C, et al. Restoration of flow following haemodialysis catheter thrombus. Analysis of rt-PA infusion in tunnelled dialysis catheters. J Clin Pharm Ther 2004;29:517-520
21. Haire WD, Deitcher SR, Mullane KM et al. Recombinant urokinase for restoration of patency in occluded central venous access devices. A double-blind, placebocontrolled trial. Thromb Haemost 2004; 92:575-582
22. Andris DA, Krzywda EA. Central venous catheter occlusion: Successful management strategies. Medsurg Nurs 1999;8:229-237
23. Whigham CJ, Greenbaum MC, Fisher RG, et al. Incidence and management of catheter occlusion in implantable arm ports: results in 391 patients. J Vasc Interv Radiol 1999;10:767-774
24. Meers C, Toffelmire EB. Urokinase efficacy in the restoration hemodialysis catheter function. J CANNT 1998;8: 17-19
25. Ng R, Li X, Tu T, Semba CP et al. Alteplase for treatment of occluded peripherally inserted central catheters: safety and efficacy in 240 patients. J Vasc Interv Radiol 2004;15:45-49
26. Bowers L, Speroni KG, Jones L et al. Comparison of occlusion rates by flushing solutions for peripherally inserted central catheters with positive pressure Luer-activated devices. J Infus Nurs 2008;31: 22-27
27. Northsea C. Continuous quality improvement: improving hemodialysis catheter patency using urokinase. Anna J 1996;23:567- 71,615.